USA Compression Partners LPNYSE: USAC

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

USA Compression (USAC) projects distributable cash flow, adjusted EBITDA, and net income to be between $340 million and $360 million, $555 million and $575 million, and $95 million and $115 million, respectively, for 2024.

USAC is cutting back on expansion CAPEX spending in order to lower its high leverage ratio and strengthen its balance sheet. The company is counting on increasing EBITDA by effectively investing capital in unused units, but longer lead times for new equipment could hinder its competitive position. The company may face difficulties in sustaining growth once all idle capacity is utilized.

USA Compression (USAC) reported earnings 30 days ago. What's next for the stock?

USA Compression (USAC) anticipates distributable cash flow, adjusted EBITDA and net income in the range of $310-$330 million, $555-$575 million and $95-$115 million, respectively, for 2024.

The headline numbers for USA Compression (USAC) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

USA Compression (USAC) anticipates $270-$280 million in distributable cash flow, $500-$510 million in adjusted EBITDA and $73-$83 million in net income for 2023.